Novavax to commence COVID-19 vaccine trial with Nucleus Network
15 April 2020 US-based clinical-stage biotechnology company Novavax (NASDAQ: NVAX) has called upon the expertise of Australian based Nucleus Network (Nucleus) to commence Phase 1 clinical trials for its COVID-19 vaccine trials. As part of the urgent global…
Cancer diagnostic companies Sienna and BARD1 announce merger
14 April 2020 (Announced 8 April 2020) The merger of Sienna Cancer Diagnostics Ltd (“Sienna”, ASX:SDX) and BARD1 Life Sciences Limited (“BARD1”, ASX:BD1) will create a well-resourced, Australian-based cancer diagnostics company with a global presence. The combined entity…
NHMRC gives $2m for COVID-19 research in areas of urgent need
13 April 2020 The National Health and Medical Research Council (NHMRC) will provide an additional $2m of funding for COVID-19 research that will generate maximum benefits for the Australian public. The funding is for nine critical COVID-19 research projects as…
New virus in bats linked to AIDS-like disease decimating koalas
14 April 2020 Devastated by summer’s unprecedented firestorms, Australia’s koalas are facing a potentially more serious and enduring existential threat from a fellow mammal – the bat. A new collaborative study led by Burnet Institute and CSIRO scientists…
Burnet’s COVID-19 self-isolation study
14 April 2020 Understanding people’s experiences and needs and ability to successfully self-isolate for COVID-19 is the goal of a new Burnet Institute study to inform current and future pandemic response. Led by Professor Margaret Hellard AM, the…
Grey Innovation to Lead Industry Consortium to Build Ventilators in Victoria
9. April 2020 Grey Innovation is pleased to announce that as the leader of a Victorian industry consortium, it has received backing from the Victorian Goverment in the form of a $500 thousand grant for the project’s feasibility…
Researchers design ventilation hoods for hospital beds to help contain COVID-19 spread
9 April 2020 University of Melbourne researchers working in collaboration with Western Health have designed a personal ventilation hood for hospital beds to help contain the droplet spread of coronavirus (COVID-19) in intensive care units (ICUs). The transparent,…
Immutep’s Partner, EOC Pharma, Continues to Advance Efti in Breast Cancer
8 April 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), is pleased to inform that EOC Pharma (“EOC”) and Immutep jointly discussed the current AIPAC results and confirmed plans to continue advancing Efti (designated as…
Post-Deployment In Wuhan Hospitals, MUVi Is Now Seeking To Scale-Up UV Light Productions For Australian Healthcare Facilities
7 April 2020 Murray McDonald, the director of Australian MedTech startup MUVi (Mobile UV innovation) is seeking $200K to produce an additional batch of UV lights to supply Australian hospitals. “We are rapidly scaling up our UV lights…
A test for COVID-19 risk, infectivity and immunity
7 April 2020 Monash scientists are repurposing technology they developed recently to make a rapid test to determine who: has immunity to coronavirus remains infectious is at risk of developing a severe form of the disease. A team,…
Robert Bosch Australia – Manufacturers FOR Manufacturers
7 April 2020 Posted on behalf of Robert Bosch Australia in regards to COVID-19 assistance: “We are designers and builders of manual to automated manufacturing systems, robotics and testing systems which can be used in the manufacturing of anything…
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
7 April 2020 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one,…
